JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B6666 RJR 2429 dihydrochloride

Summary: nAChR agonist that displays selectivity for α4β2

<26.12 mg/mL
B6697 AF-DX 384

Summary: M2/M4 selective antagonist

insoluble in ethanol; <23.93 mg/mL
B6832 SCH 28080

Summary: H+,K+-ATPase inhibitor

Soluble in DMSO
B6867 Palmitoylisopropylamide

Summary: FAAH inhibitor

Soluble in DMSO
B7311 Polygodial

Summary: TRPA1 channel activator

Soluble in DMSO
A4148 NVP-BSK805 2HCl

Target: JAK

Summary: JAK2 inhibitor

≥30.8 mg/mL
A4106 Scriptaid
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and cell-permeable

insoluble in H2O; ≥13.1 mg/mL
A4130 ENMD-2076

Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms

Summary: Selective Aurora A/Flt3 inhibitor

insoluble in H2O; ≥18.75 mg/mL
A3564 Luliconazole

Summary: Azole antifungal agent(interdigital tinea pedis)

insoluble in H2O; ≥17.71 mg/mL
A3918 Vilazodone

Summary: Combined SSRI and 5-HT1A receptor partial agonist

≥43.67 mg/mL